Hospitalist Doctors in Frisco, TX Accepting Medicare

4 Hospitalist doctors found. Showing 1 - 4

Nirmit Dilip Desai, M.D., M.P.H. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5500 Frisco Square Blvd, Frisco, TX 75034 Phone: 469-269-1780    Fax: 469-713-8599

Jeffrey James Genato, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1427 Crockett Dr, Frisco, TX 75033 Phone: 972-955-9880    Fax: 972-293-4410

Dr. Sefanit Gebretsadik, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4645 Avon Ln Ste 215, Frisco, TX 75033 Phone: 903-990-0001

Sri Venkateswara Ch Yedlapalli, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3520 Preston Rd, Suite 108, Frisco, TX 75034 Phone: 214-843-4623    Fax: 214-436-5792

News Archive

Teens who experience manic phase of bipolar disorder more likely to engage in high risk sexual behaviors

Although research has shown that teens with mental health disorders are more likely to engage in high risk sexual behaviors, like unprotected sex, a new study from the Bradley Hasbro Children's Research Center suggests there is an additional risk associated with certain psychiatric diagnoses.

Refusing surgery decreases chance of beating esophageal cancer, study finds

Patients with esophageal cancer who refuse surgery when it is recommended are less likely to survive long term than similar groups of patients who undergo an operation, according to research presented today at the 54th Annual Meeting of The Society of Thoracic Surgeons.

Independent evaluation of PMI presented to U.S. Congress

The Center for Global Health and Development (CGHD) at Boston University on Thursday delivered its report on the President's Malaria Initiative (PMI), released in February, to the U.S. Congress, IIP Digital reports, noting the "independent evaluation team finds that the [PMI] has been 'very successful' in reducing children's deaths from the mosquito-borne parasitic disease, but also warns that the program must gear up if those gains are to be sustained."

Mylan confirms Frova patent challenge

Mylan Inc. today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Endo Pharmaceuticals in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Frovatriptan Succinate EQ, 2.5 mg base tablets.

KAIST researchers identify principles of gene network for colon tumorigenesis

The principles of the gene network for colon tumorigenesis have been identified by a KAIST research team. The principles will be used to find the molecular target for effective anti-cancer drugs in the future. Further, this research gained attention for using a systems biology approach, which is an integrated research area of IT and BT.

Read more Medical News

› Verified 5 days ago